TY - JOUR
T1 - Multidisciplinary management of acromegaly
T2 - A consensus
AU - Giustina, Andrea
AU - Barkhoudarian, Garni
AU - Beckers, Albert
AU - Ben-Shlomo, Anat
AU - Biermasz, Nienke
AU - Biller, Beverly
AU - Boguszewski, Cesar
AU - Bolanowski, Marek
AU - Bollerslev, Jens
AU - Bonert, Vivien
AU - Bronstein, Marcello D.
AU - Buchfelder, Michael
AU - Casanueva, Felipe
AU - Chanson, Philippe
AU - Clemmons, David
AU - Fleseriu, Maria
AU - Formenti, Anna Maria
AU - Freda, Pamela
AU - Gadelha, Monica
AU - Geer, Eliza
AU - Gurnell, Mark
AU - Heaney, Anthony P.
AU - Ho, Ken K.Y.
AU - Ioachimescu, Adriana G.
AU - Lamberts, Steven
AU - Laws, Edward
AU - Losa, Marco
AU - Maffei, Pietro
AU - Mamelak, Adam
AU - Mercado, Moises
AU - Molitch, Mark
AU - Mortini, Pietro
AU - Pereira, Alberto M.
AU - Petersenn, Stephan
AU - Post, Kalmon
AU - Puig-Domingo, Manuel
AU - Salvatori, Roberto
AU - Samson, Susan L.
AU - Shimon, Ilan
AU - Strasburger, Christian
AU - Swearingen, Brooke
AU - Trainer, Peter
AU - Vance, Mary L.
AU - Wass, John
AU - Wierman, Margaret E.
AU - Yuen, Kevin C.J.
AU - Zatelli, Maria Chiara
AU - Melmed, Shlomo
N1 - Funding Information:
The 13th Acromegaly Consensus Conference was supported by unrestricted educational grants from Ipsen and Pfizer Inc. Scientific sponsorship of the meeting was provided by Cedars-Sinai Medical Center, Los Angeles, CA.
Funding Information:
AG is consultant for Chiasma, Genevant, Ipsen, Pfizer and Recordati and received research grants from Ipsen, Novartis and Pfizer to his Institution.
Funding Information:
AB has received research funding from Pfizer and travel and speaker grants from Novartis and Ipsen.
Funding Information:
VB has received research grants from Pfizer, and has served on advisory boards for Pfizer.
Funding Information:
PC has received unrestricted research and educational grants from Ipsen, Novartis, Crinetics and Pfizer on behalf of the Service of Endocrinology and Reproductive Diseases, Hôpitaux Universitaires Paris-Saclay and Association Recherche Endocrinologie Bicêtre, and has served as investigator (principal or coordinator) for clinical trials funded by Novartis, Pfizer, Ipsen, Italpharmaco, Chiasma. PC gave lectures for Ipsen, Novartis, and Pfizer. All the fees and honoraria are paid to his Institution or Research Association.
Funding Information:
PUF has received research grant to her institution for clinical research studies from Pfizer, Novartis, Ipsen and Chiasma.
Funding Information:
AGI has received institution-directed research grants from Chiasma, Strongbridge and Novartis and served as consultant for Tiburio.
Funding Information:
MPD has recived research grants from Pfizer and Novartis, has served on advisory boards for Pfizer, Novartis and Ipsen, and served as speaker for Novartis, Ipsen and Pfizer.
Funding Information:
SLS has served as an advisor and/or investigator for Novartis, Chiasma, Pfizer, and Ipsen, and has received investigator-initiated funding from Novartis.
Funding Information:
SM has received consulting fees from Chiasma, Crinetics, Ionis, Ipsen and research grants to the institution from Pfizer.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The 13th Acromegaly Consensus Conference was held in November 2019 in Fort Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and neurosurgeons who considered optimal approaches for multidisciplinary acromegaly management. Focused discussions reviewed techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities are used alone or in combination. Effects of treatment on patient outcomes were considered, along with strategies for optimizing and personalizing therapeutic approaches. Expert consensus recommendations emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.
AB - The 13th Acromegaly Consensus Conference was held in November 2019 in Fort Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and neurosurgeons who considered optimal approaches for multidisciplinary acromegaly management. Focused discussions reviewed techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities are used alone or in combination. Effects of treatment on patient outcomes were considered, along with strategies for optimizing and personalizing therapeutic approaches. Expert consensus recommendations emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.
KW - Acromegaly
KW - Consensus
KW - Medical therapy
KW - Multidisciplinary management
KW - Pituitary tumor centers of excellence
KW - Radiotherapy
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=85090779118&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090779118&partnerID=8YFLogxK
U2 - 10.1007/s11154-020-09588-z
DO - 10.1007/s11154-020-09588-z
M3 - Review article
C2 - 32914330
AN - SCOPUS:85090779118
VL - 21
SP - 667
EP - 678
JO - Reviews in Endocrine and Metabolic Disorders
JF - Reviews in Endocrine and Metabolic Disorders
SN - 1389-9155
IS - 4
ER -